Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA)

Historical Holders from Q2 2020 to Q3 2025

Symbol
LYRA on Nasdaq
Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
1.64M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-1
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 1.06% $84.3K 702K Nantahala Capital Management, LLC 30 Sep 2024
PERCEPTIVE ADVISORS LLC 15.55% $22.2K 256K Perceptive Advisors LLC 12 Aug 2025

Institutional Holders of Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 0 $0 -$26 0
2025 Q2 300 $26.00 -$3.2M $0.09 1
2025 Q1 25.6M $3.23M -$199K $0.13 55
2024 Q4 26.9M $5.54M -$1.49M $0.21 51
2024 Q3 32.5M $8.36M -$117K $0.26 60
2024 Q2 32.7M $9.06M -$111M $0.28 49
2024 Q1 45.6M $283M +$21M $6.22 77
2023 Q4 42.4M $222M +$30M $5.24 60
2023 Q3 31.9M $125M -$8.07M $3.91 44
2023 Q2 33.7M $138M +$60.9M $4.11 38
2023 Q1 18.9M $38.1M -$359K $2.01 30
2022 Q4 19.1M $59.9M -$364K $3.14 34
2022 Q3 19.2M $96M -$619K $5.01 33
2022 Q2 19.3M $109M +$80.6M $5.65 31
2022 Q1 5.02M $20.2M -$475K $4.02 24
2021 Q4 5.13M $22.4M -$3.69M $4.36 31
2021 Q3 6.67M $60.8M -$2.65M $9.13 33
2021 Q2 6.98M $56M -$6.44M $8.03 38
2021 Q1 7.56M $87.6M -$11.8M $11.59 49
2020 Q4 8.6M $98M +$10.2M $11.40 43
2020 Q3 7.66M $85.7M +$6.83M $11.18 39
2020 Q2 7.04M $79.8M +$79.8M $11.34 43